Chinese BCI Firms Unveil Innovations in Visual Restoration and Motor Recovery at Shanghai Conference; Several File IPO Prospectuses

China Youth Daily Client, reported by Wei Qimeng (China Youth Daily · China Youth Network) — On December 4th, the "Brain-Computer Interface Product Release Conference" of the 2025 Brain-Computer Interface Conference was held in Shanghai. Experts in the brain-computer interface field and representatives of upstream and downstream enterprises in the industry chain attended the conference to jointly witness the innovative achievements of brain-computer interface technology and discuss new paths for industrial development.

Seven companies appeared in sequence, releasing five invasive new products and two non-invasive new products, covering fields such as neuromodulation, vision restoration, motor function recovery, and sleep intervention.

Zhang Shiqiang, Executive Director and Chief Product Officer of Shanghai Stepped Medical Technology Co., Ltd., introduced the second-generation 256-channel wireless implantable brain-computer interface system and a new generation of neuromodulation engineering prototype based on flexible neural microelectrode technology. This system, adhering to the core principle of "serious medical care," significantly enhances the accuracy of neural signal acquisition and device compatibility, providing more reliable "brain control" solutions for patients with motor dysfunction.

SceneRay Co., Ltd. Chairman Ning Yihua shared "Advances in the Clinical Application of Brain-Computer Dual-Target Multi-Circuit Neuromodulation." Focusing on the application of deep brain stimulation technology, SceneRay's "brain pacemaker" effectively improves symptoms such as tremors and stiffness in Parkinson's disease patients by sending precise electrical pulses to the neural nuclei; in the field of mental illness treatment, the company has made substantial progress in innovative 0 to 1 research for diseases such as obsessive-compulsive disorder, drug addiction, and autism.

"Singularity" Approaching: Over 100-Channel Invasive Flexible Brain-Computer Interface and Electrode Implantation Introduced by Song Qi, Founder & CEO of BCIFlex Medical Technology Co., Ltd.Robot》. The "Ultra-Hundred-Channel Invasive Flexible Brain-Computer Interface System," composed of high-throughput ultra-thin flexible electrodes and a fully implantable wireless collector, supports synchronous acquisition of cellular-level action potentials. In October this year, the system completed the first clinical implantation in China, and the new generation of highest thousand-channel products has completed preliminary development. BCIFlex simultaneously launched an electrode implantation robot, which can accurately, intelligently, and efficiently complete flexible electrode implantation, providing assurance for the future large-scale clinical application of invasive flexible brain-computer interfaces.

The implantable brain-computer interface visual reconstruction system developed by Liu Bingqi, associate researcher of the Institute of Automation of the Chinese Academy of Sciences and founder & CEO of MingShi Brain-Machine, integrates virtual reality with multi-channel neuromodulation technology. Through the cooperative work of the RV-IPG stimulation module and the VPU processing unit, it outputs precise electrical stimulation signals combined with virtual scenes to achieve visual function assessment and reconstructive intervention, bringing new possibilities for restoring sight to visually impaired patients.

Founder of Shenfu Jianxing (Shanghai) Medical Device Co., Ltd., Jia Fumin, Delivered a Speech titled "Implantable Brain-Spinal Interface Technology Helps Paralyzed Individuals Walk Again," Introducing the Innovative Concept of a "Brain-Spinal Interface." This technology involves implanting electrodes into the brain's motor cortex and the spinal cord to create a "neural bridge" between the brain and spinal cord. It captures the patient’s movement intentions in real time and stimulates corresponding nerves, enabling voluntary control of lower limbs in paraplegic patients. Compared with traditional brain-computer interfaces, its integrated implant design significantly reduces surgical trauma and enhances signal acquisition stability.

Jiang Jian, Chairman of Shanghai Quanlan Technology Co., Ltd., released the "Lanmao Sleep Pod" personalized insomnia regulation solution. Based on more than a decade of research, the solution relies on the unique "Insomnia Brain Region Map" and high-throughput closed-loop EEG system to accurately locate individual insomnia targets. It intervenes in abnormal brain regions through transcranial microcurrent stimulation, achieving "high efficiency, no side effects, and long-lasting results" as verified by multiple institutions, breaking through the bottleneck of traditional insomnia treatments.

Wang Suji, CEO of Hangzhou Shenzong Technology Co., Ltd., presented "High-Precision Wearable Sleep Monitoring and Analysis Technology." The polysomnography device he leads obtained Class II medical device certification with the advantage of being the "world's lightest," covering over 800 hospitals in China. In 2024, it ranked first among Chinese-produced brands with a market share of 15.17%.

At the press conference, Li Wenyu, Secretary General of the Brain-Computer Interface Industry Alliance, introduced that the alliance has currently gathered 315 member units, always taking the empowerment of digital and intelligent transformation in the brain-computer interface field as its core mission; many practitioners in the industry are committed to the industrial development with the common dream of overcoming the frontiers of brain science.

Source: China Youth Daily Client